Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective

Total article views   HTML views PDF downloads Totals
11,670 Dovepress* 10,550+ 2,077 12,627
PubMed Central* 1,120 463 1,583
Totals 11,670 2,540 14,210
*Since 23 August 2012
+Since July 2016

View citations on PubMed Central and Google Scholar